Cargando…

The effectiveness of nonsteroidal anti-inflammatory drugs and acetaminophen in reduce the risk of amyotrophic lateral sclerosis? A meta-analysis

To test the hypothesis that aspirin, non-aspirin nonsteroidal anti-infammatory drugs (NA-NSAIDs), or acetaminophen can reduce the risk of ALS, we conducted a systematic review and meta-analysis of related previous studies. A comprehensive search was conducted on the PubMed, Embase, Cochrane Library...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Min Cheol, Kwak, Sang Gyu, Park, Jin-Sung, Park, Donghwi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479139/
https://www.ncbi.nlm.nih.gov/pubmed/32901053
http://dx.doi.org/10.1038/s41598-020-71813-1
_version_ 1783580206052671488
author Chang, Min Cheol
Kwak, Sang Gyu
Park, Jin-Sung
Park, Donghwi
author_facet Chang, Min Cheol
Kwak, Sang Gyu
Park, Jin-Sung
Park, Donghwi
author_sort Chang, Min Cheol
collection PubMed
description To test the hypothesis that aspirin, non-aspirin nonsteroidal anti-infammatory drugs (NA-NSAIDs), or acetaminophen can reduce the risk of ALS, we conducted a systematic review and meta-analysis of related previous studies. A comprehensive search was conducted on the PubMed, Embase, Cochrane Library and SCOPUS databases. It included studies published up to 29 February 2020 that fulfilled our inclusion criteria. Aspirin, acetaminophen and NA-NSAIDs use information, between the ALS and control groups, was collected for the meta-analysis. Rates of aspirin, NA-NSAID, and acetaminophen use in ALS group, compared with control group were investigated. In the results, only three studies that relate the risk of ALS to aspirin, NA-NSAIDs and acetaminophen use satisfied the inclusion criteria for the meta-analysis. Regarding aspirin, the studies did not show any statistically significant difference in aspirin use between the ALS and control groups (Odds ratio, 1.04 [95% confidence interval, 0.90–1.21]). NA-NSAIDs and acetaminophen use, however, did show up statistically significant differences in between the ALS and control groups. (Odds ratio, 0.82 [95% confidence interval, 0.73–0.91]) and (Odds ratio, 0.80 [95% confidence interval, 0.69–0.93]). However, our study has some limitations. Firstly, we only included a small number of studies. Secondly, the included studies did not control for past medical history, which may have confounded their results, and in turn, could have caused bias in our study. Thirdly, in this meta-analysis, the ALS patients were not subdivided into sporadic or familial type. Lastly, the studies also did not consider the types of NSAIDs and dosages used of each drug. For more convincing evidence regarding the effectiveness of aspirin, NA-NSAIDs and acetaminophen to reduce the risk of ALS occurrence, more qualified prospective studies are required. In conclusion, the use of NA-NSAIDs and acetaminophen is associated with a decreased risk for the development of ALS. In contrast, aspirin did not have any effect on the reduction of the risk of ALS occurrence.
format Online
Article
Text
id pubmed-7479139
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-74791392020-09-11 The effectiveness of nonsteroidal anti-inflammatory drugs and acetaminophen in reduce the risk of amyotrophic lateral sclerosis? A meta-analysis Chang, Min Cheol Kwak, Sang Gyu Park, Jin-Sung Park, Donghwi Sci Rep Article To test the hypothesis that aspirin, non-aspirin nonsteroidal anti-infammatory drugs (NA-NSAIDs), or acetaminophen can reduce the risk of ALS, we conducted a systematic review and meta-analysis of related previous studies. A comprehensive search was conducted on the PubMed, Embase, Cochrane Library and SCOPUS databases. It included studies published up to 29 February 2020 that fulfilled our inclusion criteria. Aspirin, acetaminophen and NA-NSAIDs use information, between the ALS and control groups, was collected for the meta-analysis. Rates of aspirin, NA-NSAID, and acetaminophen use in ALS group, compared with control group were investigated. In the results, only three studies that relate the risk of ALS to aspirin, NA-NSAIDs and acetaminophen use satisfied the inclusion criteria for the meta-analysis. Regarding aspirin, the studies did not show any statistically significant difference in aspirin use between the ALS and control groups (Odds ratio, 1.04 [95% confidence interval, 0.90–1.21]). NA-NSAIDs and acetaminophen use, however, did show up statistically significant differences in between the ALS and control groups. (Odds ratio, 0.82 [95% confidence interval, 0.73–0.91]) and (Odds ratio, 0.80 [95% confidence interval, 0.69–0.93]). However, our study has some limitations. Firstly, we only included a small number of studies. Secondly, the included studies did not control for past medical history, which may have confounded their results, and in turn, could have caused bias in our study. Thirdly, in this meta-analysis, the ALS patients were not subdivided into sporadic or familial type. Lastly, the studies also did not consider the types of NSAIDs and dosages used of each drug. For more convincing evidence regarding the effectiveness of aspirin, NA-NSAIDs and acetaminophen to reduce the risk of ALS occurrence, more qualified prospective studies are required. In conclusion, the use of NA-NSAIDs and acetaminophen is associated with a decreased risk for the development of ALS. In contrast, aspirin did not have any effect on the reduction of the risk of ALS occurrence. Nature Publishing Group UK 2020-09-08 /pmc/articles/PMC7479139/ /pubmed/32901053 http://dx.doi.org/10.1038/s41598-020-71813-1 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Chang, Min Cheol
Kwak, Sang Gyu
Park, Jin-Sung
Park, Donghwi
The effectiveness of nonsteroidal anti-inflammatory drugs and acetaminophen in reduce the risk of amyotrophic lateral sclerosis? A meta-analysis
title The effectiveness of nonsteroidal anti-inflammatory drugs and acetaminophen in reduce the risk of amyotrophic lateral sclerosis? A meta-analysis
title_full The effectiveness of nonsteroidal anti-inflammatory drugs and acetaminophen in reduce the risk of amyotrophic lateral sclerosis? A meta-analysis
title_fullStr The effectiveness of nonsteroidal anti-inflammatory drugs and acetaminophen in reduce the risk of amyotrophic lateral sclerosis? A meta-analysis
title_full_unstemmed The effectiveness of nonsteroidal anti-inflammatory drugs and acetaminophen in reduce the risk of amyotrophic lateral sclerosis? A meta-analysis
title_short The effectiveness of nonsteroidal anti-inflammatory drugs and acetaminophen in reduce the risk of amyotrophic lateral sclerosis? A meta-analysis
title_sort effectiveness of nonsteroidal anti-inflammatory drugs and acetaminophen in reduce the risk of amyotrophic lateral sclerosis? a meta-analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479139/
https://www.ncbi.nlm.nih.gov/pubmed/32901053
http://dx.doi.org/10.1038/s41598-020-71813-1
work_keys_str_mv AT changmincheol theeffectivenessofnonsteroidalantiinflammatorydrugsandacetaminopheninreducetheriskofamyotrophiclateralsclerosisametaanalysis
AT kwaksanggyu theeffectivenessofnonsteroidalantiinflammatorydrugsandacetaminopheninreducetheriskofamyotrophiclateralsclerosisametaanalysis
AT parkjinsung theeffectivenessofnonsteroidalantiinflammatorydrugsandacetaminopheninreducetheriskofamyotrophiclateralsclerosisametaanalysis
AT parkdonghwi theeffectivenessofnonsteroidalantiinflammatorydrugsandacetaminopheninreducetheriskofamyotrophiclateralsclerosisametaanalysis
AT changmincheol effectivenessofnonsteroidalantiinflammatorydrugsandacetaminopheninreducetheriskofamyotrophiclateralsclerosisametaanalysis
AT kwaksanggyu effectivenessofnonsteroidalantiinflammatorydrugsandacetaminopheninreducetheriskofamyotrophiclateralsclerosisametaanalysis
AT parkjinsung effectivenessofnonsteroidalantiinflammatorydrugsandacetaminopheninreducetheriskofamyotrophiclateralsclerosisametaanalysis
AT parkdonghwi effectivenessofnonsteroidalantiinflammatorydrugsandacetaminopheninreducetheriskofamyotrophiclateralsclerosisametaanalysis